Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Christopher Baker

Vascular & Interventional Radiology Newport Beach, CA Medical Doctor

NPI 1013059872 CMS profile 317986

4041 MacArthur Blvd Ste 360, Newport Beach, CA 92660

Open in the dashboard

General payments

$115,739

303 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Christopher Baker of Newport Beach, CA is reported in the CMS Open Payments database as having received $115,739 across 303 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,094 16
2024 General $26,326 38
2023 General $9,729 27
2022 General $38,137 73
2021 General $31,431 77
2020 General $4,978 33
2019 General $4,044 39

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Christopher Baker
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Christopher Baker were reported at $1,094. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Christopher Baker Vascular & Interventional Radiology median Middle half National median
2019 $4,044 $422 $125–$1,555 $163
2020 $4,978 $200 $68–$652 $114
2021 $31,431 $280 $99–$866 $132
2022 $38,137 $433 $137–$1,497 $149
2023 $9,729 $506 $152–$2,019 $160
2024 $26,326 $556 $175–$1,930 $164
2025 $1,094 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. MicroVention, Inc. $50,851 88 payments
  2. Stryker Corporation $34,453 80 payments
  3. Philips Electronics North America Corporation $10,379 4 payments
  4. Balt USA, LLC $5,599 13 payments
  5. Medtronic USA, Inc. $4,311 12 payments
  6. Medtronic, Inc. $3,682 29 payments
  7. Siemens Medical Solutions USA, Inc. $2,509 15 payments
  8. Penumbra, Inc. $1,304 14 payments
  9. Corindus Inc. $855 4 payments
  10. Inari Medical, Inc. $755 9 payments
  11. Other $1,040 35 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $43,075 23 payments
  2. Consulting Fee $39,178 18 payments
  3. Travel and Lodging $26,137 58 payments
  4. Food and Beverage $7,322 203 payments
  5. Entertainment $27 1 payment
Products named General payments · program years 2019–2025
  1. WEB ANEURYSM EMBOLIZATION SYSTEM Neurological Product $46,363 53 payments
  2. SURPASS EVOLVE $32,476 36 payments
  3. (BI2) IGT Systems Undivided $10,352 3 payments
  4. AXS VECTA 71 $5,278 1 payment
  5. Optima Coil System $3,850 4 payments
  6. STENT $3,000 2 payments
  7. WEB Aneurysm Embolization System Neurological Product $2,955 6 payments
  8. Pipeline $1,564 4 payments
  9. Artis icono floor $1,376 6 payments
  10. WEB $1,144 11 payments
  11. Other $13,653 209 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

15

Median for Interventional Radiology: 38

Drug cost

$134

Median for Interventional Radiology: $333

Branded share of claims

100%

Median for Interventional Radiology: 53%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Clopidogrel Clopidogrel Bisulfate Brand 15 $134

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 554 Part D prescribers listed as Interventional Radiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 167 billing codes

Paid by Medicare

$149,944

Medicare's payments for the services billed

Medicare patients

718

Average age 77

Services billed

1,729

368 women, 350 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 54%
Ischemic heart disease 39%
Chronic kidney disease 39%
Cancer 37%
Atrial fibrillation 33%
Diabetes 31%
Heart failure 31%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

303 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular & Interventional Radiology in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record